Guangzhou Kingmed Diagnostics Group Co Ltd (603882) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.047x

Based on the latest financial reports, Guangzhou Kingmed Diagnostics Group Co Ltd (603882) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥327.19 Million ≈ $47.88 Million USD) by net assets (CN¥6.95 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Guangzhou Kingmed Diagnostics Group Co L net asset quality index to measure how much of total assets are equity-financed.

Guangzhou Kingmed Diagnostics Group Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Guangzhou Kingmed Diagnostics Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603882 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Guangzhou Kingmed Diagnostics Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Kingmed Diagnostics Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
CBIZ Inc NYSE:CBZ	-0.013x
Cimpress plc F:3UF	0.036x
Ral Yatirim Holding AS IS:RALYH	0.230x
Central China Land Media Co Ltd SHE:000719	-0.033x
Liberty Global PLC NASDAQ:LBTYA	0.011x
City Union Bank Limited NSE:CUB	-0.382x
Suzhou Crystal Clear Chemical Co Ltd SHE:300655	0.062x
Harbin Boshi Automation Co Ltd SHE:002698	0.011x

Annual Cash Flow Conversion Efficiency for Guangzhou Kingmed Diagnostics Group Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Guangzhou Kingmed Diagnostics Group Co L market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.86 Billion ≈ $1.00 Billion	CN¥1.20 Billion ≈ $175.89 Million	0.175x	+44.54%
2024-12-31	CN¥7.48 Billion ≈ $1.09 Billion	CN¥906.35 Million ≈ $132.63 Million	0.121x	-15.80%
2023-12-31	CN¥8.55 Billion ≈ $1.25 Billion	CN¥1.23 Billion ≈ $180.11 Million	0.144x	-34.39%
2022-12-31	CN¥8.87 Billion ≈ $1.30 Billion	CN¥1.95 Billion ≈ $285.03 Million	0.219x	-31.44%
2021-12-31	CN¥6.52 Billion ≈ $954.46 Million	CN¥2.09 Billion ≈ $305.54 Million	0.320x	-18.53%
2020-12-31	CN¥3.88 Billion ≈ $567.27 Million	CN¥1.52 Billion ≈ $222.88 Million	0.393x	+38.16%
2019-12-31	CN¥2.33 Billion ≈ $340.32 Million	CN¥661.40 Million ≈ $96.78 Million	0.284x	+5.00%
2018-12-31	CN¥1.96 Billion ≈ $286.16 Million	CN¥529.62 Million ≈ $77.50 Million	0.271x	+66.60%
2017-12-31	CN¥1.74 Billion ≈ $255.22 Million	CN¥283.53 Million ≈ $41.49 Million	0.163x	-36.92%
2016-12-31	CN¥1.13 Billion ≈ $165.88 Million	CN¥292.14 Million ≈ $42.75 Million	0.258x	+12.24%
2015-12-31	CN¥959.84 Million ≈ $140.46 Million	CN¥220.39 Million ≈ $32.25 Million	0.230x	-60.20%
2014-12-31	CN¥391.72 Million ≈ $57.32 Million	CN¥225.97 Million ≈ $33.07 Million	0.577x	+97.31%
2013-12-31	CN¥258.41 Million ≈ $37.81 Million	CN¥75.55 Million ≈ $11.06 Million	0.292x	-32.66%
2012-12-31	CN¥203.69 Million ≈ $29.81 Million	CN¥88.44 Million ≈ $12.94 Million	0.434x	--

About Guangzhou Kingmed Diagnostics Group Co Ltd

SHG:603882 China Diagnostics & Research

Market Cap

$1.81 Billion

CN¥12.36 Billion CNY

Market Cap Rank

#6404 Global

#1237 in China

Share Price

CN¥26.69

Change (1 day)

+1.21%

52-Week Range

CN¥22.16 - CN¥37.03

All Time High

CN¥164.39